ICYMI: President of @IsomorphicLabs @maxjaderberg spoke with @business’s @shiringhaffary about applying AI to drug discovery and accelerating the future of medicine. #BloombergTech# "To me that was the jumping off point, to say hey look, I really want to now focus the application of AI on something really really important." Watch the full session here ⏯️

ICYMI: President of @IsomorphicLabs @maxjaderberg joined @business ’s @shiringhaffary to explain their strategy for targeting diseases—focusing on broad platform capability over single-target discovery. #BloombergTech# "We’ve built this general engine that you can apply to many different disease areas." Watch the full session here ⏯️

The biosecurity landscape is rapidly evolving. To stay ahead of future outbreaks, we’re partnering with @IsomorphicLabs to outline our approach to bioresilience. Here’s how we’re deploying frontier AI to build proactive defenses for global health →

Learn how Isomorphic Labs' Drug Design Engine uses AI to help solve disease with Anton Osokin from @IsomorphicLabs! Stop by the Google booth (#411#) at 10AM to learn more. #ICLR2026# #IsomorphicLabs# @GoogleDeepMind

Just shared some changes we’re making to the teams at @GoogleDeepMind. @DemisHassabis is stepping up to become Chair of @GoogleDeepMind & Chief Scientist of Alphabet, in addition to leading @IsomorphicLabs. He’ll be able to dedicate his time and focus on shaping the future of AGI and scientific discovery. It’s work that is vitally important to Alphabet and humanity, and I can’t imagine a better person than Demis to do it. He’ll stay closely connected to Koray and the GDM teams. @Koraykv will become the SVP, @GoogleDeepMind, responsible for all aspects of model development, GDM research, and @Geminiapp & dev teams. Koray has been at GDM for 13 years and is a world-renowned expert in the field, starting our deep learning team and driving breakthroughs like WaveNet & DQN. GDM is in great hands! Excited for this next chapter. You can read my note along with the message Demis sent to @GoogleDeepMind here:

Tackling the most complex scientific challenges requires a proactive approach to safety. Today, together with @IsomorphicLabs, we're sharing our joint approach to bio-resilience. Learn more:

I’ve always believed the No.1 application of AI should be to improve human health. That work started with AlphaFold, and now at @IsomorphicLabs with the mission to reimagine drug discovery and one day solve all disease! We are turbocharging that goal with $2.1B in new funding.

Isomorphic Labs president Max Jaderberg thinks that artificial intelligence will be used to develop all medicines in the future — the only question is how quickly that future will arrive

Isomorphic Labs, an AI-powered drug discovery startup spun out of Alphabet’s Google DeepMind, is in early talks to raise new funds at a valuation of at least $40 billion, according to people familiar with the effort.